Navigation Links
Oncothyreon's PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover
Date:11/16/2009

SEATTLE, Nov. 16 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (the "Company") today announced that the Company's product candidate PX-866, a PI-3 kinase inhibitor, has been selected by Windhover Information, Inc., as one of the Top 10 most promising oncology projects in development that is available for partnering.

The selection was made by an independent committee assembled by Windhover Information, a leading provider of business information products and services to senior executives in the pharmaceutical, biotechnology and medical device industries. As a selected company, Oncothyreon will present data on PX-866 at Windhover's Therapeutic Area Partnerships conference on November 17-19, 2009, in Boston, MA.

PX-866 is an inhibitor of the PI-3-kinase/PTEN/AKT pathway, an important survival signaling pathway that is activated in many types of human cancer. Oncothyreon is currently conducting a Phase 1 trial of PX-866 in patients with advanced metastatic cancer. Based upon the results seen in this trial to date, including the preliminary data presented at the American Society of Oncology Annual Meeting (ASCO) earlier this year, Oncothyreon has made the decision to move PX-866 into Phase 2 clinical development in the first half of 2010. The Phase 2 development program is currently expected to include two or more trials of PX-866 in combination with chemotherapy or other targeted agents and as a single agent.

"Preliminary results from our ongoing trial of PX-866 have demonstrated that the activity of the target, PI-3 kinase, can be down-regulated at doses well below the maximally tolerated dose identified in the intermittent dosing arm," said Robert L. Kirkman, M.D., President and Chief Executive Officer of Oncothyreon. "As reported at ASCO, we have also had several patients with prolonged stable disease
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Data for Oncothyreons PX-12 and PX-866 presented at AACR Annual Meeting
2. Oncothyreon files investigational new drug application for PX-866 oncology compound
3. Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
4. Oncothyreons PX-866 is effective in preclinical model of pulmonary fibrosis
5. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
6. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
7. EntreMeds Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
8. ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase
9. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
10. CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform
11. Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMeds Selective Kinase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , Mar. 03, 2015 Research and Markets ... addition of Jain PharmaBiotech,s new report "Gene ... their offering. , Gene therapy ... nonviral vectors and cell therapy with genetically modified ... drug delivery and various routes of administration as ...
(Date:3/3/2015)... 2015 Elsevier,s DirectCourse online ... competency-based training to comply with new CMS requirements ... a new crosswalk tool to help providers ... for direct service workers as a means to comply ... regulations. CMS amended the regulations, effective March ...
(Date:3/3/2015)... March 3, 2015  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... with a focus on protecting the microbiome, announced today that ... present at the 27th Annual ROTH Conference being held on ... in Dana Point, CA. ... 2015 at 1:00 p.m. (Pacific Time). A live ...
(Date:3/3/2015)... 2015  PDL BioPharma, Inc. (PDL or the Company) ... third of three shareholder lawsuits filed in the fall ... On February 2, 2015, a securities lawsuit that was ... a putative class of purchasers of the Company,s stock, ... (D. Nev.), was voluntarily dismissed without prejudice.  Shortly thereafter, ...
Breaking Biology Technology:Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 2Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 3Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 2Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 3Synthetic Biologics to Present at the 27th Annual ROTH Conference 2PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit 2
... Small Interfering RNAs (siRNAs) are , ... mRNAs for degradation via a cellular process termed RNA interference , ... described , the use of vectors ... knockdown studies (for a review, see Tuschl, 2002). Two different , ...
... The RNaseAlert QC System, when used in conjunction , ... rapid and , ultra-sensitive assay for ... RNaseAlert QC System also detects a variety of other nucleases, , ... mung bean nuclease, and Benzonase. In ...
... , ... sample lysis with MagMAX magnetic bead-based RNA isolation , ... Procedure is compatible with fresh, , ... Streamlined procedure allows high , ...
Cached Biology Technology:More siRNA Vectors for RNA Interference 2More siRNA Vectors for RNA Interference 3More siRNA Vectors for RNA Interference 4More siRNA Vectors for RNA Interference 5More siRNA Vectors for RNA Interference 6More siRNA Vectors for RNA Interference 7Measuring RNase Activity A Real-time Kinetic Analysis 2Measuring RNase Activity A Real-time Kinetic Analysis 3Measuring RNase Activity A Real-time Kinetic Analysis 4Measuring RNase Activity A Real-time Kinetic Analysis 5High Throughput RNA Isolation for High Performance Microarray Analysis 2High Throughput RNA Isolation for High Performance Microarray Analysis 3High Throughput RNA Isolation for High Performance Microarray Analysis 4
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced ... Overview" report to their offering. , ... an individual is who she/he is claiming to be, and ... person,s unique physical characteristics, such as fingerprint, hand or palm ...
(Date:1/22/2015)... 13, 2015 Technology Showcase, Hall E -   EyeLock ... today announced it will showcase its EyeLock ID technology integrated ... Department of Energy,s Oak Ridge National Laboratory (ORNL) ... EyeLock,s iris identity authentication technology is being used to validate ...
(Date:1/22/2015)... POINT ROBERTS, Washington , January 20, 2015 ... technology and tech stocks, releases video from the CES 2015 ... security consultant Apollo Robbins . Apollo shows ... Wocket™ biometric smart wallet, a product of NXT-ID, Inc. (NASDAQ: ...
Breaking Biology News(10 mins):Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
... of biological processes; it is an active participant. Protein folding ... the solvent play a key role. So far, the emphasis ... of the protein backbone and its side chains. Researchers led ... to detect changes in the proteinwater network during protein folding ...
... food according to how stocked their nests are, say ... bumblebees return to the nest from a successful foraging ... mates to also go out and find food. Scientists ... response from all bees. But new research from Queen ...
... The prospect of climate change sparking food and water ... previously thought, with new research by an Australian climate ... key parts of the region., Recent projections from the ... storm activity in the eastern Mediterranean would decline this ...
Cached Biology News:Keeping an eye on the surroundings 2Smells like bees' spirit 2Climate change may boost Middle East rainfall 2
Mouse IL-31 RA Biotinylated Affinity Purified PAb...
Sf21 cells derived from Spodoptera frugiperda ovarian cells are recommended for high-level production of recombinant proteins. Higher expression levels of some proteins are seen due to the larger ce...
... consists of universal lysis buffer, PCR mix, ... 100 25 l volume PCR reactions. This ... negative or positive rod and coccus bacteria, ... Cereus, Staphylococcus Aureus, Streptococcus Agalactiae, and etc. ...
...
Biology Products: